EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
EUPRAXIA PHARMACEUTICALS INC.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026
$6.95+0.33 (+4.98%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
41.1%
25M of 60M shares
Institutional holders
68
18 new, 5 sold out
Net institutional buying
3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Joseph S. Freedman | 5,843,215 | 9.00% | 13D (active) amendment | Mar 13, 2026 |
| Beutel, Goodman & Co Ltd. | 4,058,899 | 8.00% | 13G (passive) | Sep 30, 2025 |
| Morgan C. Frank | 4,015,248 | 7.70% | 13G (passive) amendment | Mar 31, 2026 |
| Robert Disbrow | 3,568,150 | 7.00% | 13G (passive) amendment | Sep 30, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EPRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Beutel, Goodman & Co Ltd. | 3,627,864 | 6.02% | $23.81K | −38,601 | 0.18% |
| Affinity Asset Advisors, LLC | 1,650,000 | 2.74% | $10.91M | +60,995 | 0.49% |
| Balyasny Asset Management L.P. | 1,350,015 | 2.24% | $8.92M | +15 | 0.01% |
| Vivo Capital, LLC | 1,350,000 | 2.24% | $8.92M | – | 0.81% |
| Scotia Capital Inc. | 1,343,726 | 2.23% | $8.78M | +1,548 | 0.03% |
| PFM Health Sciences, LP | 1,210,661 | 2.01% | $8.00M | +669,790 | 0.69% |
| Great Point Partners LLC | 1,200,000 | 1.99% | $7.93M | – | 1.50% |
| Jupiter Topco LLC | 1,046,000 | 1.73% | $6.85M | New | 0.00% |
| Rubric Capital Management LP | 867,424 | 1.44% | $5.73M | +176,254 | 0.05% |
| Ikarian Capital, LLC | 809,741 | 1.34% | $5.35M | −405,000 | 0.58% |
| Woodline Partners LP | 746,864 | 1.24% | $4.94M | +306,313 | 0.02% |
| Point72 Asset Management, L.P. | 730,284 | 1.21% | $4.83M | −237,291 | 0.01% |
| Ameriprise Financial Inc | 711,024 | 1.18% | $4.70M | +61,950 | 0.00% |
| Redmile Group, LLC | 611,400 | 1.01% | $4.04M | −88,600 | 0.27% |
| Seven Fleet Capital Management LP | 610,785 | 1.01% | $4.04M | +177,270 | 0.67% |
| UBS Group AG | 519,211 | 0.86% | $3.43M | −243,424 | 0.00% |
| Citadel Advisors LLC | 502,011 | 0.83% | $3.32M | +271,835 | 0.00% |
| Millennium Management LLC | 441,586 | 0.73% | $2.92M | New | 0.00% |
| Alyeska Investment Group, L.P. | 375,000 | 0.62% | $2.48M | – | 0.01% |
| Picton Mahoney Asset Management | 360,878 | 0.60% | $2.39M | New | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 68 | 25M | 41.1% | 18 / 22 | 18 / 5 | 5M | 3M |
| Q1 2026 | 55 | 22M | 36.9% | 22 / 19 | 6 / 3 | 9M | 0M |
| Q4 2025 | 36 | 14M | 23.1% | 15 / 8 | 4 / 6 | 3M | 2M |
| Q3 2025 | 27 | 13M | 21.3% | 15 / 7 | 2 / 2 | 11M | 0M |
| Q2 2025 | 14 | 2M | 4.0% | 3 / 6 | 5 / 0 | 1M | 0M |
| Q1 2025 | 11 | 2M | 3.6% | 4 / 4 | 2 / 2 | 0M | 0M |
| Q4 2024 | 9 | 2M | 3.0% | 2 / 2 | 4 / 1 | 0M | 0M |
| Q3 2024 | 8 | 2M | 3.0% | 3 / 3 | 0 / 3 | 0M | 0M |
| Q2 2024 | 8 | 2M | 2.9% | 8 / 0 | 0 / 0 | 2M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of EPRX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 36,211 | 0.06% | $256.74K | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 300 | 0.00% | $1.98K | 0.00% | Jun 30, 2026 |